FDA issued a Warning Letter to AllerQuest LLC on 6/24/2019 for a later inspection.
483 AllerQuest Sep 2017

483 AllerQuest Sep 2017

Jose Hernandez FDA, Nealie Newberger FDA$119.00 - Available Now

FDA investigators audited the AllerQuest - Plainville, CT, United States facility and issued inspectional observations (via FDA 483) on 19 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Sep 2017
  • Location: Plainville, United States
  • FEI: 3006900385
Add To Cart